Common anti-cancer therapies induce somatic mutations in stem cells of healthy tissue

[1]  R. van Boxtel,et al.  Elevated Mutational Age in Blood of Children Treated for Cancer Contributes to Therapy-Related Myeloid Neoplasms , 2022, Cancer discovery.

[2]  W. Vermeij,et al.  Chemotherapy Side-Effects: Not All DNA Damage Is Equal , 2022, Cancers.

[3]  E. Cuppen,et al.  Precancerous liver diseases do not cause increased mutagenesis in liver stem cells , 2021, Communications Biology.

[4]  E. Cuppen,et al.  MutationalPatterns: the one stop shop for the analysis of mutational processes , 2021, BMC Genomics.

[5]  R. Verhaak,et al.  Radiotherapy is associated with a deletion signature that contributes to poor outcomes in cancer patients , 2021, Nature Genetics.

[6]  H. Clevers,et al.  Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids. , 2021, Cell stem cell.

[7]  M. Stratton,et al.  Somatic mutation landscapes at single-molecule resolution , 2021, Nature.

[8]  S. Behjati,et al.  Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment. , 2021, Blood.

[9]  O. Slabý,et al.  Second primary malignancies in colorectal cancer patients , 2021, Scientific Reports.

[10]  Jose Espejo Valle-Inclan,et al.  GRIDSS2: comprehensive characterisation of somatic structural variation using single breakend variants and structural variant phasing , 2021, Genome Biology.

[11]  Inigo Martincorena,et al.  Reliable detection of somatic mutations in solid tissues by laser-capture microdissection and low-input DNA sequencing , 2020, Nature Protocols.

[12]  A. Gonzalez-Perez,et al.  The evolution of hematopoietic cells under cancer therapy , 2020, Nature Communications.

[13]  A. Need,et al.  Mutational signature in colorectal cancer caused by genotoxic pks+E. coli , 2020, Nature.

[14]  M. Stratton,et al.  Tobacco exposure and somatic mutations in normal human bronchial epithelium , 2019, Nature.

[15]  M. Parkes,et al.  Somatic Evolution in Non-neoplastic IBD-Affected Colon , 2020, Cell.

[16]  Martin S. Taylor,et al.  Pervasive lesion segregation shapes cancer genome evolution , 2019, Nature.

[17]  Jose Espejo Valle-Inclan,et al.  GRIDSS, PURPLE, LINX: Unscrambling the tumor genome via integrated analysis of structural variation and copy number , 2019, bioRxiv.

[18]  Inigo Martincorena,et al.  Somatic mutations and clonal dynamics in healthy and cirrhotic human liver , 2019, Nature.

[19]  P. Watkins,et al.  Drug-induced liver injury , 2019, Nature Reviews Disease Primers.

[20]  A. Gonzalez-Perez,et al.  The mutational footprints of cancer therapies , 2019, bioRxiv.

[21]  E. Cuppen,et al.  5-Fluorouracil treatment induces characteristic T>G mutations in human cancer , 2019, Nature Communications.

[22]  E. Cuppen,et al.  Early divergence of mutational processes in human fetal tissues , 2019, Science Advances.

[23]  S. Morganella,et al.  A Compendium of Mutational Signatures of Environmental Agents , 2019, Cell.

[24]  Ville Mustonen,et al.  The repertoire of mutational signatures in human cancer , 2018, Nature.

[25]  S. Sleijfer,et al.  Pan-cancer whole genome analyses of metastatic solid tumors , 2018, bioRxiv.

[26]  M. Stratton,et al.  The landscape of somatic mutation in normal colorectal epithelial cells , 2018, Nature.

[27]  M. Stratton,et al.  Universal Patterns of Selection in Cancer and Somatic Tissues , 2018, Cell.

[28]  Mi Ni Huang,et al.  In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors , 2017, bioRxiv.

[29]  E. Cuppen,et al.  Measuring mutation accumulation in single human adult stem cells by whole-genome sequencing of organoid cultures , 2017, Nature Protocols.

[30]  Edwin Cuppen,et al.  MutationalPatterns: comprehensive genome-wide analysis of mutational processes , 2016, Genome Medicine.

[31]  Recinda L. Sherman,et al.  Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival , 2017, Journal of the National Cancer Institute.

[32]  Mingming Jia,et al.  COSMIC: somatic cancer genetics at high-resolution , 2016, Nucleic Acids Res..

[33]  Hans Clevers,et al.  Tissue-specific mutation accumulation in human adult stem cells during life , 2016, Nature.

[34]  Christophe Badie,et al.  Mutational signatures of ionizing radiation in second malignancies , 2016, Nature Communications.

[35]  B. Vogelstein,et al.  Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, Science.

[36]  A. Morris,et al.  Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, BDJ.

[37]  J. Hoeijmakers,et al.  Aging: not all DNA damage is equal. , 2014, Current opinion in genetics & development.

[38]  Eric J Feuer,et al.  Secular trends in colon and rectal cancer relative survival. , 2013, Journal of the National Cancer Institute.

[39]  Wendy S. W. Wong,et al.  Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..

[40]  Hans Clevers,et al.  Intestinal Crypt Homeostasis Results from Neutral Competition between Symmetrically Dividing Lgr5 Stem Cells , 2010, Cell.

[41]  S. Frank.  Somatic evolutionary genomics: Mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration , 2010, Proceedings of the National Academy of Sciences.

[42]  I. Couzin.  Faculty Opinions recommendation of Evolution in health and medicine Sackler colloquium: Somatic evolutionary genomics: mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration. , 2010 .

[43]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[44]  Hans Clevers,et al.  Crypt stem cells as the cells-of-origin of intestinal cancer , 2009, Nature.

[45]  J. Pinheiro,et al.  Linear, Generalized Linear, and Nonlinear Mixed Effects Models , 2006 .

[46]  P. Johnston,et al.  5-Fluorouracil: mechanisms of action and clinical strategies , 2003, Nature Reviews Cancer.

[47]  P. Sham,et al.  A note on the calculation of empirical P values from Monte Carlo procedures. , 2002, American journal of human genetics.

[48]  C. Sklar,et al.  Second cancers in survivors of childhood cancer , 2002, Nature Reviews Cancer.